Kenneth Randall Chien | |
---|---|
Nationality | American |
Alma mater | |
Known for |
|
Parent | Luther Chien (father) |
Awards | Pasarow Award (1996) |
Scientific career | |
Fields |
|
Institutions |
|
Kenneth R. Chien (born 1951)[1] is an American doctor and medical scientist[2] who has been a research director at Karolinska Institute, in Stockholm, since 2013.[3] Chien has several papers with over 1,000 citations and a h-index of 132.[2] His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute,[4] led to his co-founding, in 2010, of ModeRNA Therapeutics.[5] In 2018, the company re-branded as Moderna, Inc.[6] Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters,[7] the Austrian Academy of Sciences,[8] and has received an honorary doctorate from the University of Edinburgh.[9]